ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Geriatric Medicine

Top Geriatric Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN KELLY MD

Geriatric Medicine

5,034

$264K

239
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $60

ARIF NAZIR MD

Geriatric Medicine

4,627

$298K

150
146 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

28%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $60

ROBIN BECK MD

Geriatric Medicine

2,191

$170K

147
145 are 65+

23%
patients receiving schedule two controlled substances

Avg: 9%

25%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $60

DALE COCKRELL M.D.

Geriatric Medicine

1,481

$148K

124
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$100
Average prescription price

Avg: $60

TODD JAMES MD

Geriatric Medicine

1,610

$128K

147
144 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $60

PAUL O'BRIEN DO

Geriatric Medicine

626

$31.2K

129
66 are 65+

29%
patients receiving schedule two controlled substances

Avg: 9%

25%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $60

ELLA BOWMAN MD PHD

Geriatric Medicine

549

$46K

60
60 are 65+

27%
patients receiving schedule two controlled substances

Avg: 9%

25%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $60

DIANE ELROD D.O.

Geriatric Medicine

917

$49K

187
102 are 65+

18%
patients receiving schedule two controlled substances

Avg: 9%

30%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $60

GREG SACHS MD

Geriatric Medicine

157

$6,366

24
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $60

JOHN STUY MD

Geriatric Medicine

5,739

$406K

294
233 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

24%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $60

GLENDA WESTMORELAND MD

Geriatric Medicine

4,917

$406K

193
191 are 65+

24%
patients receiving schedule two controlled substances

Avg: 9%

33%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $60

ADNAN ARSEVEN MD

Geriatric Medicine

1,073

$62.8K

78
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $60

KATHLEEN UNROE MD

Geriatric Medicine

1,091

$87.4K

37
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $60

MALAZ BOUSTANI MD

Geriatric Medicine

715

$60K

81
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$84
Average prescription price

Avg: $60

CHRISTOPHER NELSON M.D.

Geriatric Medicine

982

$64.6K

199
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $60

SURYA NALLARI M.D.

Geriatric Medicine

19,371

$1.26M

716
609 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $60

WILLIAM HARDESTY MD

Geriatric Medicine

12,441

$541K

450
443 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $60

KATHRYN MULLIGAN MD

Geriatric Medicine

15,037

$796K

598
550 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $60

ABDALI JAN M.D.

Geriatric Medicine

15,475

$915K

542
413 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $60

RICHARD CHAMBERS MD

Geriatric Medicine

19,095

$1.07M

668
577 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

DUAN PIERCE M.D.

Geriatric Medicine

6,008

$303K

256
221 are 65+

19%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $60

RAJARAJESWARI MAJETY MD

Geriatric Medicine

4,330

$271K

245
229 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $60

MAURO AGNELNERI M.D.

Geriatric Medicine

6,156

$410K

482
310 are 65+

20%
patients receiving schedule two controlled substances

Avg: 9%

32%
patients receiving schedule three controlled substances

Avg: 17%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $60

B. WELLS MD

Geriatric Medicine

22,226

$1.18M

537
438 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

26%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $60

DIANE HEALEY MD

Geriatric Medicine

11,524

$695K

422
416 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

6%
patients receiving schedule three controlled substances

Avg: 17%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank